This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.
HAYES, Inc.. Hypoglossal nerve stimulation for the treatment of obstructive sleep apnea. Lansdale: HAYES, Inc.. Directory Publication. 2016
Purpose of Technology: Hypoglossal nerve stimulation (HGNS) is a potential treatment alternative for patients with moderate-to-severe obstructive sleep apnea (OSA) who have tried continuous positive airway pressure (CPAP) but have failed to find relief, or for OSA patients who cannot use CPAP therapy. Fully implanted HGNS systems sense breathing patterns and deliver mild electrical stimulation to the genioglossus muscle via the hypoglossal nerve and maintain airway patency during sleep.
Relevant Questions: Does HGNS therapy reduce OSA severity, improve sleep parameters, and increase quality of life? Is HGNS therapy safe? Have definitive patient selection criteria been established for the use of HGNS therapy?
Subject indexing assigned by CRD
Electric Stimulation Therapy; Humans; Hypoglossal Nerve; Sleep Apnea, Obstructive
Country of organisation
An English language summary is available.
Address for correspondence
HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: firstname.lastname@example.org
Date abstract record published